Few mouse tumor models, however, are conducted in the orthotopic site. Even if orthotopic implantation studies are done, the therapy is typically initiated in mice harboring a small tumor volume ...

today announced positive data from orthotopic pancreatic cancer models demonstrating that subcutaneously administered SIL204 effectively reduces both primary tumor growth and metastatic spread.